Download Mini-Update - Missouri Cancer Registry

MCR MINI-UPDATE
APRIL 2017
Fellow Registrars,
This year’s NCRW slogan “Putting the Pieces Together” is certainly apt as you try to pull pieces
of information from various parts of the patient record into a cohesive and comprehensive
abstract using coding rules from multiple manuals. We thank each of you for the considerable
effort that you put into this work each day. Your conscientious work helps to assure that
researchers and clinicians have a more complete “puzzle” image of trends in cancer incidence
and outcomes of cancer care. I hope that you have some celebration or awareness activities
planned that week. If you can make it to Columbia, please join us for lunch at 11:30 on Tuesday
April 11 at Golden Corral in Columbia. Meanwhile, if you have 2 minutes to indulge in play, you
can try your hand at putting together the 24 pieces of this virtual jigsaw puzzle:
http://www.jigsawplanet.com/?rc=play&pid=177151082545&pieces=24 (If it shows as
completed, click restart in the settings icon at lower left. You can also increase the number of
pieces using the upper right “Play As” list) Have fun!
DUE DATES
Large hospitals (>500 cases/yr.) are to report Sept 2016 cases by April 15 and smaller facilities (<300
cases /yr.) report the 3nd Quarter of 2016 by April 15.
EDUCATION
NAACCR Webinars
Attention: This month the live NAACCR Webinar is on the second Thursday instead of the first Thursday
of the month.
Live: April 13, 2017, 8-11 a.m., Collecting Cancer Data: Lip and Oral Cavity. To attend the live broadcast
in Columbia, sign up here. http://www.signupgenius.com/go/30e0e49a4a82caafa7-naaccr15
NAACCR Recordings: Earn 3 CEs by viewing recorded webinars. Check out our Education and Training
page to find out how you can receive access to the recorded NAACCR Webinars.
http://mcr.umh.edu/mcr-education.php
GoToMeeting
Upcoming: May 10, 2017, 10-11 a.m., Breast Surgery Codes & MPH Rules. Sign up here:
http://www.signupgenius.com/go/30e0e49a4a82caafa7-gotomeeting0510
GoToMeeting Recordings: Previous GoToMeeting presentations are posted to the MCR website as
recordings. http://mcr.umh.edu/mcr-education.php
MCR Help-Line
Reach us at 1-800-392-2829 during regular office hours, or leave a message; a member of our QA team
will return your call within one business day.
Massachusetts Free Educational Webcast
Save the Date Tuesday May 16, 2017 8 a.m. – 4 p.m.
Once again the Massachusetts Cancer Registry and Dana-Farber institute will sponsor a free all-day
webcast. The agenda has been posted and is attached to this email. You can listen to any or all of the
presentations from your computer or device. No registration needed to listen via the web. URL for log-
1
MCR MINI-UPDATE
APRIL 2017
in to the webcast will be emailed to all on this distribution list a few days prior to the workshop. NCRA
CEUs will be available.
Florida Cancer Data System (FCDS)
FCDS Educational Webcast Series recorded from 2/16/2017 presentation: Female GYN Sites: Ovary,
Adnexa & Peritoneum, Uterus, Cervix, Vagina, and Vulva. Access recording at:
https://fcds.med.miami.edu/inc/educationtraining.shtml (FCDS Webcasts Tab)
MCR NEWS
Edits v16D and 2017 reporting
As outlined in detail within my special blast email to this group on March 13, the MO v16D edit metafile
is available to your vendors and on our website. We plan to install the new edit metafile on Web Plus
later today (April 3), expecting that all facilities should have it installed and/or have addressed the issues
cited in my email during their recent abstracting. If you have specific cases you had been holding
because of faulty v16C edits, you will finally be able to upload them to Web Plus. You may continue to
upload cases even if you are not yet in v16D, but you may find a few cases with errors flagged by the
new edits. If the file is rejected, simply resolve those errors and re-submit the whole file.
Mid-year Timeliness/Completeness Assessment
Because Web Plus was not able to accept v16 cases until five months later than usual, and because
some facilities are waiting on installation of edits v16D to validate held cases that had previously faulty
edits applied, MCR will not issue mid-year letters assessing timeliness and completeness of 2016 case
reporting. You are encouraged to assess your own progress and to work with administrators to provide
you the resources to complete 2016 case abstracting for submission by July 15, 2017. At this point in the
year (end of March) you should have cases through Sept. 2016 abstracted (75% of your expected
caseload for the year).
ABSTRACTING TIPS
Diagnostic Confirmation
Before assigning diagnostic confirmation code 7 based on imaging results, be sure the radiography
report contains reportable terminology listed on page 3 of FORDS. If no reportable terminology is used
in the imaging report but there is physician documentation that the results represent malignancy, assign
diagnostic code 8 – Clinical diagnosis only (other than 5, 6 or 7). Reportability is based on the physician’s
clinical judgement that the findings represent malignancy.
STANDARD SETTTER/NATIONAL NEWS
NAACCR: What You Need to Know for 2017 – Important Revisions!
This document has been revised. Please see Appendix C Revision Control for a table of the changes.
https://www.naaccr.org/implementation-guidelines/
NAACCR: Annual Report to the Nation, 1975-2014, Featuring Survival
“The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National
Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR)
collaborate to provide annual updates on cancer occurrence and trends in the United States. This
Annual Report highlights survival rates. Cancer death rates continue to decrease in the United States.
2
MCR MINI-UPDATE
APRIL 2017
However, progress in reducing death rates and improving survival is limited for several cancer types,
underscoring the need for intensified efforts to discover new strategies for prevention, early detection,
and treatment and to apply proven preventive measures broadly and equitably.” This work would not be
possible without contributions by the entire cancer surveillance community. Thank you!
Report: https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnci/djx030
Infographics: https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnci/djx030
NCRA: Policy Statement on Monitoring Changes in Cancer Registry Operations
NCRA has issued a policy statement on Monitoring Changes in Cancer Registry Operations to express the
vital role of the CTR in the abstraction process, and the value they add to the data collection process.
3
MCR MINI-UPDATE
APRIL 2017
The Informatics Committee took the lead in drafting the policy statement and corresponding white
paper. Their work is in response to the changing relationship between the cancer registry profession and
technology. Read the policy statement and the white paper.
NCRA: Two New Staging Short videos at http://www.cancerregistryeducation.org/best-practices
Using the Manuals: Breast (16 min.)
Using the Manuals: Lung (21 min.)
National Quality Measures Clearing House
This is not required by MCR, but many cancer programs want to institute quality measures; some
measures can be assessed using your registry data. You can set up a free account to get emails about
quality measure ideas at: https://qualitymeasures.ahrq.gov/accounts/signinlanding For example, I saw
two measures this month that you might volunteer to track for your facility from registry data:
Lung cancer: percentage of patients with clinical stage IB or higher, but no evidence of metastatic
disease, who have had a mediastinal lymph node sampling procedure performed prior to the initiation
of curative intent therapy. 2016 Dec. NQMC:010991 American College of Chest Physicians - Medical
Specialty Society.
Lung cancer: percentage of patients with lung cancer who have an American Joint Committee on Cancer
(AJCC) current edition clinical lung cancer stage documented prior to curative intent therapy. 2016 Dec.
NQMC:010992 American College of Chest Physicians - Medical Specialty Society.
American Cancer Society Publications
Colorectal Cancer Facts & Figures 2017-2019
https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/colorectalcancer-facts-and-figures/colorectal-cancer-facts-and-figures-2017-2019.pdf
Colorectal cancer statistics, 2017
http://onlinelibrary.wiley.com/doi/10.3322/caac.21395/full
REGISTRY TO RESEARCH
Future of Testicular Germ Cell Tumor Incidence in the United States: Forecast Through 2026 (CINA data)
https://www.naaccr.org/future-testicular-germ-cell-tumor-incidence-united-states-forecast-2026/
Over the Past 20 Years, 5-Year Mortality in Men with Advanced Prostate Cancer Has Dropped
Significantly (Danish Registry)
http://www.practiceupdate.com/c/49897/32/1/?elsca1=emc_conf_ASCOGU2017Post1&elsca2=email&elsca3=practiceupdate_onc&elsca4=201721_ASCOGU2017Post1&elsca5=conference&rid=NTU2MjE4MTE1NjYS1&lid=10332481
Testosterone and Prostate Cancer Risk: Favorable and Less Aggressive (Swedish registry data)
http://ascopubs.org/doi/full/10.1200/JCO.2016.69.5304
Beyond Positive Margins and Extracapsular Extension: Evaluating the Utilization and Clinical Impact of
Postoperative Chemoradiotherapy in Resected Locally Advanced Head and Neck Cancer (NCDB data)
http://ascopubs.org/doi/full/10.1200/JCO.2016.68.2336
4
MCR MINI-UPDATE
APRIL 2017
Death within 1 Month of Diagnosis in Childhood Cancer: An Analysis of Risk Factors and Scope of the
Problem (SEER data)
http://ascopubs.org/doi/full/10.1200/JCO.2016.70.3249
Higher Risk of Adverse Outcomes for Births to Young CA Survivors (North Carolina Cancer Registry data)
http://jamanetwork.com/journals/jamaoncology/fullarticle/2612803
Factors Associated with Early Mortality among Patients with De Novo Metastatic Breast Cancer: A
Population‐Based Study (SEER data)
http://theoncologist.alphamedpress.org/content/early/2017/02/27/theoncologist.2016-0369
Impact of Metastatic Pattern on the Prognosis in Stage IV Breast Cancer at Initial Diagnosis (SEER data)
https://link.springer.com/article/10.1007%2Fs10549-016-4066-7
Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study (SEER data)
http://jamanetwork.com/journals/jamaoncology/article-abstract/2610293
Primary Lymphoma of the Female Genital Tract (SEER data)
http://www.gynecologiconcology-online.net/article/S0090-8258(17)30164-6/abstract
Nodular Lymphocyte Predominant Hodgkin Lymphoma in Sweden between 2000 and 2014: An Analysis
of the Swedish Lymphoma Registry
http://onlinelibrary.wiley.com/doi/10.1111/bjh.14567/abstract
NEWS & RESOURCES OF INTEREST
MU Research Findings Could Affect Vaccine, Cancer Research
http://medicine.missouri.edu/news/20170313-mystery-of-memory-cells.php
Adults with Disabilities Screened Less Often for Colorectal Cancer (MU Researcher)
http://www.ajpmonline.org/article/S0749-3797(17)30011-9/fulltext
Cancer Screening Test Use — United States, 2015
https://www.cdc.gov/mmwr/volumes/66/wr/mm6608a1.htm
Large-Scale Skin Cancer Screening Initiative Feasible
http://jamanetwork.com/journals/jamaoncology/article-abstract/2604819
ASCO: State of Cancer Care in America (infographic) and link to full text
http://www.asco.org/sites/new-www.asco.org/files/content-files/research-andprogress/documents/2017-socca-report.pdf
Temporal Trends in Treatment and Subsequent Neoplasm Risk among 5-Year Survivors of Childhood
Cancer, 1970-2015
http://jamanetwork.com/journals/jama/fullarticle/2605800
5
MCR MINI-UPDATE
APRIL 2017
Prediction of Overall Survival in Stage II and III Colon Cancer beyond the TNM System
https://academic.oup.com/annonc/article/2981957/Prediction-of-overall-survival-in-stage-II-and-III
Poor Diet in Adolescence May Raise Risk of Early Breast Cancer
http://www.practiceupdate.com/c/50343/2/1/?elsca1=emc_enews_dailydigest&elsca2=email&elsca3=practiceupdate_onc&elsca4=oncology&elsca5=newsletter&rid=NTU2MjE4
MTE1NjYS1&lid=10332481
Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study
http://ascopubs.org/doi/full/10.1200/JCO.2016.70.3116
Soy Linked to Prolonged Survival in Some Breast Cancer Patients
http://onlinelibrary.wiley.com/doi/10.1002/cncr.30615/abstract
Nine US Deaths Linked to Breast Implant-Associated Cancer
https://medicalxpress.com/news/2017-03-deaths-linked-breast-implant-associated-cancer.html#jCp
Pathological Characterization of Male Breast Cancer
http://www.ejcancer.com/article/S0959-8049(17)30726-8/pdf
Estimating the Risks of Breast Cancer Radiotherapy: Evidence from Modern Radiation Doses to the Lungs
and Heart and From Previous Randomized Trials
http://ascopubs.org/doi/full/10.1200/JCO.2016.72.0722
Detecting Blood-Based Biomarkers in Metastatic Breast Cancer: A Systematic Review of Their Current
Status and Clinical Utility
http://www.mdpi.com/1422-0067/18/2/363
Effect of Palliative Radiotherapy on Painful Bone Metastases
http://jamanetwork.com/journals/jamaoncology/article-abstract/2601221
Stereotactic Ablative Body Radiotherapy for the Treatment of Spinal Oligometastases
http://www.clinicaloncologyonline.net/article/S0936-6555(17)30079-1/pdf
Hormonal Maintenance Tx Ups PFS in Low-Grade Serous Cancer
http://ascopubs.org/doi/abs/10.1200/JCO.2016.71.0632
Biomarker in Nasal Passages May ID Lung Cancer in Smokers
https://academic.oup.com/jnci/article/109/7/djw327/3053477/Shared-Gene-Expression-Alterations-inNasal-and
Rare Thyroid Malignancies: An Overview for the Oncologist
http://www.clinicaloncologyonline.net/article/S0936-6555(17)30069-9/pdf
Clinical Implications of Microscopic Extrathyroidal Extension in Patients with Papillary Thyroid Carcinoma
http://www.sciencedirect.com/science/article/pii/S1368837517300283
6
MCR MINI-UPDATE
APRIL 2017
The New Key Player in Head and Neck Cancer Care
http://www.curetoday.com/articles/the-new-key-player-in-head-and-neck-cancer-care?p=1
FDA Approves Bavencio for Metastatic Merkel Cell Carcinoma
http://www.practiceupdate.com/c/51190/2/1/?elsca1=emc_enews_dailydigest&elsca2=email&elsca3=practiceupdate_onc&elsca4=oncology&elsca5=newsletter&rid=NTU2MjE4
MTE1NjYS1&lid=10332481
FDA Approves Zejula for Certain Female Cancers
http://www.practiceupdate.com/c/51349/2/1/?elsca1=emc_enews_dailydigest&elsca2=email&elsca3=practiceupdate_onc&elsca4=oncology&elsca5=newsletter&rid=NTU2MjE4
MTE1NjYS1&lid=10332481
Scripps Florida Scientists Develop New Drug Delivery Method for Cancer Therapy
http://www.medicalnewstoday.com/releases/316461.php
Body Weight Trajectories and Risk of Esophageal and Gastric Cardia Adenocarcinomas: A Pooled Analysis
of NIH-AARP and PLCO Studies
http://www.nature.com/bjc/journal/vaop/ncurrent/abs/bjc201729a.html
Vasectomy Cleared of Association with Advanced Prostate Cancer
http://ascopubs.org/doi/full/10.1200/JCO.2016.70.0062
Baseline Tumor Volume as a Prognostic Factor in Recurrent Glioblastoma
https://academic.oup.com/neuro-oncology/article-lookup/doi/10.1093/neuonc/now187
Metastatic Kidney Cancer or a Separate Lung Cancer? Expert Urges Patients, Doctors to Learn the
Difference
http://www.curetoday.com/articles/metastatic-kidney-cancer-or-a-separate-lung-cancer-expert-urgespatients-doctors-to-learn-the-difference-?p=1
Report Links Excess Weight to Eight More Cancer Types
http://www.cancertodaymag.org/Winter2016/Pages/Report-Links-Excess-Weight-to-Eight-MoreCancer-Types.aspx
The Impact of Vitamin D Pathway Genetic Variation and Circulating 25-hydroxyvitamin D on Cancer
Outcome: Systematic Review and Meta-analysis
http://www.nature.com/bjc/journal/vaop/ncurrent/full/bjc201744a.html
The Risk of Melanoma and Hematologic Cancers in Patients with Psoriasis
http://www.eblue.org/article/S0190-9622(16)30896-9/fulltext
7
MCR MINI-UPDATE
APRIL 2017
It was certainly a busy month in cancer research publishing! I hope you agree that it is an
exciting time to be active in the cancer field!
Thanks again for all you do,
Nancy H. Rold, CTR
Operations Manager
Missouri Cancer Registry and Research Center
8
MCR MINI-UPDATE
APRIL 2017
Massachusetts Cancer Registry (MCR)
Educational Workshop
Hosted by
Dana-Farber / Brigham and Women’s Cancer Center (DF/BWCC)
Yawkey Building
Conference Room 307
Boston, MA 02115
Date: May 16, 2017
AGENDA
8:00 am - 8:45 am
Registration
8:45 am - 9:30 am
Welcome
Quality and Patient Safety
Joseph Jacobson, MD, Chief Quality Officer, Senior Physician,
Dana-Farber Cancer Institute (DFCI), Associate Professor of Medicine,
Harvard Medical School (HMS)
9:30 am - 10:15 am
Breast Cancer
Rachel A. Freedman, MD, MPH, Associate Clinical Director, Breast
Oncology Center, Senior Physician, DFCI, Assistant Professor of
Medicine, HMS
10:15 am - 11:00am
Stomach Cancer
Thomas A. Abrams, MD, Senior Physician, Gastrointestinal Program,
DFCI, Assistant Professor of Medicine, HMS
(Tentative)
11:00 am - 11:15 am
Break
11:15 am -11:45 am
Cancer Control Plan
Gail Merriam, MSW, MPH, Program Director, Massachusetts
Comprehensive Cancer Prevention and Control Network,
Massachusetts Department of Public Health (MDPH)
11:45 am -12:00 pm
Kentucky Query System
Susan T. Gershman, MS, MPH, PhD, CTR, Director, MCR, Office of Data
Management and Outcomes Assessment, MDPH
12:00 pm - 1:15 pm
LUNCH (on your own)
1:15 pm - 2:00 pm
Personalized Medicine
(To Be Determined)
9
MCR MINI-UPDATE
APRIL 2017
2:15 pm - 3:00 pm
Lymphomas and Leukemias
(To Be Determined)
3:00 pm - 3:45 pm
Adolescent and Young Adult Cancers
Ann S. LaCasce, MD, MMSc, Director, DF/Partners CancerCare
Hematology-Medical Oncology Program, Senior Physician, DFCI,
Associate Professor of Medicine, HMS
10